URICA THERAPEUTICS, INC.

Profile

Company Names

URICA THERAPEUTICS, INC.

Addresses

1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL 33154

Phone Numbers

781-652-4500

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$2,533,350.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-12-27 
$2,533,350.00 
$5,000,000.00 
$2,466,650.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAY 
D 
KRANZLER, M.D., PH.D. 
EXECUTIVE OFFICER, DIRECTOR
URICA THERAPEUTICS, INC.
LINDSAY 
A. 
ROSENWALD, M.D. 
DIRECTOR
OPUS POINT HEALTHCARE INNOVATIONS (OFFSHORE) FUND LTD.   |  AVENUE THERAPEUTICS, INC.   |  URICA THERAPEUTICS, INC.   |  MUSTANG BIO, INC.
VIBEKE 
S. 
STRAND, M.D. 
DIRECTOR
URICA THERAPEUTICS, INC.
MICHAEL 
S. 
WEISS 
DIRECTOR
OPUS POINT HEALTHCARE INNOVATIONS FUND, L.P.   |  CB PHARMA ACQUISITION CORP.   |  OPUS POINT HEALTHCARE INNOVATIONS (OFFSHORE) FUND LTD.   |  CHECKPOINT THERAPEUTICS, INC.   |  HELOCYTE, INC.   |  MUSTANG BIO, INC.   |  FORTRESS BIOTECH, INC.   |  CAELUM BIOSCIENCES, INC.   |  URICA THERAPEUTICS, INC.
RAYMOND 
S. 
ZHENG 
EXECUTIVE OFFICER, DIRECTOR
URICA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-01-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
HARLEY CAPITAL LLC
310046
HARLEY CAPITAL LLC
310046